The country's health insurance spending on cancer care has increased substantially in 2025 as more cancer cases are detected in the country.
According to Taiwan’s National Health Insurance Administration, nearly 1m people received cancer treatment in 2025, which is up 5% from 2020. The country’s national health insurance contributed NT$156.7bn($4.92bn) on cancer care treatment against NT$26.5bn in 2020.
Lung cancer accounted for the highest cost at NT$28.7bn, followed by breast cancer at NT$24.1bn and colorectal cancer at NT$17.3bn. Breast cancer had the most people seeking care, at nearly 199,000, followed by colorectal cancer with 120,000 and lung cancer with 110,000.
National Health Insurance spending on pancreatic cancer also increased in 2025 along with cancer screenings. The government spent NT$6.8bn on cancer screenings and expanded the age range eligible for free screenings.